Alembic operates primarily through specialized corporate entities focusing on global healthcare solutions, active pharmaceutical ingredients, and diversified industrial investments. Alembic Pharmaceuticals develops, manufactures, and markets a broad spectrum of prescription drug formulations across major therapeutic categories—including anti-infectives, cardiology, neurology, and dermatology—for both domestic and international markets. Meanwhile, Alembic Limited manages diversified business interests encompassing real estate development, chemical investments, and strategic holding assets across domestic commercial landscapes.